Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes

Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes

Conditions: Type 1 Diabetes Mellitus
Interventions: Device: Overnight CLC; Device: Sensor-Augmented Pump Therapy (SAP)
Sponsors: Sue Brown; DexCom, Inc.; Roche Diagnostics GmbH
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 22, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments